Heritage Global Partners will this March hold their 113th sale of research and development and biopharma laboratory equipment from multinational biotechnology and pharmaceutical firm Pfizer.Founded in 1849, Pfizer develops and manufactures health care products and devices. These include vaccines, and medicines used in oncology, neurology, endocrinology and immunology.
The auction opens on the 30th of March and closes on the 31st of March. Lots featured in the sale include: spectrometers, GC systems, assorted analyzers, mass spectrometers, analytical and top-load balances, HPLC systems, incubators, vacuum pumps, dissolution systems, spectrophotometers, robotic workstations, microscopes, centrifuges, consumables and disposables, liquid handling system, ULT freezers, general lab refrigerators and freezers and much more.
Asset advisory and full-service auction firm Heritage Global Partners operates across more than 25 industries, including the oil and gas, pharmaceutical, automotive and food and beverage sectors. The firm conducts around 150-200 auctions every year – ranging from single asset dispositions to entire turnkey facilities and complete factories.
For further information about this, or any other Heritage Global Partners auction, please visit:
